DISCOVERY

The discovery engine of the NExT Program is the Chemical Biology Consortium (CBC). The NCI has established this collaborative network comprising 12 of the top Specialized and Comprehensive Screening and Chemistry Centers with world-class capabilities covering high-throughput methods, bioinformatics, medicinal chemistry, and structural biology. Additionally, the highly successful Developmental Therapeutics Program (DTP) provides the resources needed to facilitate discovery and late-stage preclinical development through the final steps of development to first-in-human studies. The program is also complemented by the Center for Cancer Research's (CCR) dynamic in-house discovery research.